Mirtazapina Ethypharm (Mirtazapine)

Mirtazapine, the active ingredient in Mirtazapina Ethypharm, is a noradrenergic and specific serotonergic antidepressant (NaSSA) presented as an oral tablet for oral use. It is prescribed for the treatment of major depressive disorder in adult patients, helping to improve mood, sleep and appetite. The medication works by modulating neurotransmitter activity in the brain, leading to increased norepinephrine and serotonin signaling.

GNH USA supplies Mirtazapina Ethypharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mirtazapine is used to treat depressive disorders by enhancing noradrenergic and serotonergic neurotransmission. - Major depressive disorder: reduces depressive symptoms and improves mood. - Depressive episodes with insomnia: helps normalize sleep patterns. - Depressive episodes with anxiety: alleviates anxiety associated with depression.

Mirtazapine may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Sedation: feeling of drowsiness or sleepiness. - Increased appetite and weight gain: heightened hunger leading to weight increase. - Dry mouth: reduced salivation causing oral dryness. - Dizziness: sensation of lightheadedness or imbalance.

Serious or Rare Side Effects: - Agranulocytosis or neutropenia: severe reduction in white blood cells. - Severe hypersensitivity reactions: rash, swelling, or anaphylaxis. - Suicidal thoughts or behavior: emergence of suicidal ideation, especially early in treatment.

Before prescribing Mirtazapine, clinicians should consider several precautionary measures to ensure safe use. - Assess hepatic function: evaluate liver disease before initiating therapy. - Monitor for suicidal ideation: watch for emergence of suicidal thoughts, particularly during the first weeks. - Evaluate for hypersensitivity: discontinue if signs of allergic reaction appear. - Use caution in elderly: increased risk of sedation and falls. - Review concomitant CNS depressants: adjust doses to avoid excessive sedation. - Store at room temperature: keep in the original packaging, protect from moisture and light.

Mirtazapine can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis; avoid concurrent use. - Other serotonergic agents (e.g., SSRIs, SNRIs, tramadol): may precipitate serotonin syndrome. - CNS depressants (e.g., benzodiazepines, alcohol): can enhance sedation and respiratory depression.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may increase mirtazapine plasma levels. - Antihypertensive drugs: additive blood pressure lowering effect; monitor blood pressure.